IDENTIFICATION OF VAV2 ON 9Q34 AND ITS EXCLUSION AS THE TUBEROUS SCLEROSIS GENE TSC1

被引:76
作者
HENSKE, EP
SHORT, MP
JOZWIAK, S
BOVEY, CM
RAMLAKHAN, S
HAINES, JL
KWIATKOWSKI, DJ
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV EXPTL MED, BOSTON, MA 02115 USA
[2] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA
[3] MASSACHUSETTS GEN HOSP, DEPT NEUROL, MOLEC NEUROGENET UNIT, BOSTON, MA 02129 USA
[4] CHILDRENS HLTH CTR, DIV CHILD NEUROL, WARSAW, POLAND
[5] ERASMUS UNIV ROTTERDAM, DEPT CLIN GENET, 3015 GE ROTTERDAM, NETHERLANDS
关键词
D O I
10.1111/j.1469-1809.1995.tb01603.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A novel widely expressed homologue of the VAV oncogene, VAV2 (53% identical residues), has been identified within the critical region for the tuberous sclerosis gene, TSC1, on human chromosome 9q34. By Southern blot analysis, analysis of allele-specific transcription, and direct sequencing of the VAV2 mRNA/cDNA from patient lymphoblastoid cell lines, we demonstrate that both alleles of this gene are expressed in TSC patients and there are no significant mutations. VAV consists of a novel array of signalling domains and is thought to play an important role in signal transduction in haematopoietic tissues where it is exclusively expressed. VAV2 is likely to serve a similar role more generally in mammalian cells, but is not the TSC1 gene.
引用
收藏
页码:25 / 37
页数:13
相关论文
共 48 条
  • [1] NONSENSE MUTATIONS IN THE HUMAN BETA-GLOBIN GENE AFFECT MESSENGER-RNA METABOLISM
    BASERGA, SJ
    BENZ, EJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) : 2056 - 2060
  • [2] EXON AMPLIFICATION - A STRATEGY TO ISOLATE MAMMALIAN GENES BASED ON RNA SPLICING
    BUCKLER, AJ
    CHANG, DD
    GRAW, SL
    BROOK, JD
    HABER, DA
    SHARP, PA
    HOUSMAN, DE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 4005 - 4009
  • [3] PRODUCT OF VAV PROTOONCOGENE DEFINES A NEW CLASS OF TYROSINE PROTEIN-KINASE SUBSTRATES
    BUSTELO, XR
    LEDBETTER, JA
    BARBACID, M
    [J]. NATURE, 1992, 356 (6364) : 68 - 71
  • [4] BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297
  • [5] TYROSINE PHOSPHORYLATION OF THE VAV PROTOONCOGENE PRODUCT IN ACTIVATED B-CELLS
    BUSTELO, XR
    BARBACID, M
    [J]. SCIENCE, 1992, 256 (5060) : 1196 - 1199
  • [6] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [7] PREMATURE TRANSLATION TERMINATION MEDIATES TRIOSEPHOSPHATE ISOMERASE MESSENGER-RNA DEGRADATION
    DAAR, IO
    MAQUAT, LE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 802 - 813
  • [8] 4 NOVEL FBN1 MUTATIONS - SIGNIFICANCE FOR MUTANT TRANSCRIPT LEVEL AND EGF-LIKE DOMAIN CALCIUM-BINDING IN THE PATHOGENESIS OF MARFAN-SYNDROME
    DIETZ, HC
    MCINTOSH, I
    SAKAI, LY
    CORSON, GM
    CHALBERG, SC
    PYERITZ, RE
    FRANCOMANO, CA
    [J]. GENOMICS, 1993, 17 (02) : 468 - 475
  • [9] INTERLEUKIN-2 INDUCES TYROSINE PHOSPHORYLATION OF THE VAV PROTOONCOGENE PRODUCT IN HUMAN T-CELLS - LACK OF REQUIREMENT FOR THE TYROSINE KINASE LCK
    EVANS, GA
    HOWARD, OMZ
    ERWIN, R
    FARRAR, WL
    [J]. BIOCHEMICAL JOURNAL, 1993, 294 : 339 - 342
  • [10] FELIX CA, 1993, ONCOGENE, V8, P1203